Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-15-029975

VP and Chief Compliance Office acquired 4,000 shares (grant or award)

  • VP and Chief Compliance Office gave up 817 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Herman James L VP and Chief Compliance Office 2015-03-27 Grant or award +4,000 $6.86 $27,440 36,509 D
Herman James L VP and Chief Compliance Office 2015-03-27 Shares withheld for taxes −817 $6.88 $5,621 35,692 D
Loading xslF345X03/doc4.xml…